Pfizer third dose (booster) approved for 16 and 17 year olds
As of 3 February 2022, people aged 16 and 17 years are eligible to receive a third dose (booster) of the Pfizer COVID-19 vaccine following ATAGI’s recommendation and the Therapeutic Goods Administration (TGA) announcement on...